Literature DB >> 18550307

Anxiolytic-like effect of chronic treatment with Erythrina velutina extract in the elevated plus-maze test.

I M Raupp1, A Sereniki, S Virtuoso, C Ghislandi, E L Cavalcanti E Silva, H A Trebien, O G Miguel, R Andreatini.   

Abstract

INTRODUCTION: In Brazil, Erythrina velutina (Fabaceae) is widely used as a tranquilizer and/or sedative, and its extract exerts an anxiolytic-like effect profile in animal models, although these results may be caused by its sedative or amnesic effects. AIMS,
MATERIALS AND METHODS: Thus, this study evaluated the effect of acute and chronic (23-26 days) administrations of the hydroalcoholic extract of the stem bark of Erythrina velutina (orally) in mice submitted to the following tests: elevated plus-maze, forced swim, spontaneous locomotor activity, and habituation to active chamber. Chlordiazepoxide and imipramine were used as standard drugs.
RESULTS: In the elevated plus-maze test, chronic, but not acute, Erythrina velutina (100mg/kg) administration increased the percentage of open arm entries, an effect also seen in both acute and chronic treatments with chlordiazepoxide (7.5mg/kg). In the forced swim test, only imipramine (25mg/kg) decreased immobility time. Impairment of habituation was seen only with acute imipramine administration and with the lowest doses of Erythrina velutina extract tested in acute (10mg/kg) and chronic (50mg/kg) administrations.
CONCLUSIONS: These results suggest that chronic administration of the hydroalcoholic extract of the stem bark of Erythrina velutina exerts an anxiolytic-like effect on mice, and it could serve as a new approach for the treatment anxiety, although it may have an amnesic effect at low doses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18550307     DOI: 10.1016/j.jep.2008.04.016

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  6 in total

Review 1.  Plant-based medicines for anxiety disorders, Part 1: a review of preclinical studies.

Authors:  Jerome Sarris; Erica McIntyre; David A Camfield
Journal:  CNS Drugs       Date:  2013-03       Impact factor: 5.749

2.  Antidepressant- and anxiolytic effects of the novel melatonin agonist Neu-P11 in rodent models.

Authors:  Shao-wen Tian; Moshe Laudon; Li Han; Jun Gao; Fu-lian Huang; Yu-feng Yang; Hai-feng Deng
Journal:  Acta Pharmacol Sin       Date:  2010-06-28       Impact factor: 6.150

Review 3.  In silico approach of secondary metabolites from Brazilian herbal medicines to search for potential drugs against SARS-CoV-2.

Authors:  Tatiane R Amparo; Janaína B Seibert; Tamires C Almeida; Fernanda S F Costa; Benila M Silveira; Glenda N da Silva; Orlando D H Dos Santos; Gustavo H B de Souza
Journal:  Phytother Res       Date:  2021-04-01       Impact factor: 6.388

4.  Chronic administration of parecoxib exerts anxiolytic-like and memory enhancing effects and modulates synaptophysin expression in mice.

Authors:  Bo Wang; Xin Jin; Xin Kuang; Shaowen Tian
Journal:  BMC Anesthesiol       Date:  2017-11-13       Impact factor: 2.217

5.  Anxiolytic and anti-depressant effects of hydroalcoholic extract from Erythrina variegata and its possible mechanism of action.

Authors:  Hong-Biao Chu; Yue-De Tan; Yun-Jing Li; Bin-Bin Cheng; Bao-Qi Rao; Ling-Shan Zhou
Journal:  Afr Health Sci       Date:  2019-09       Impact factor: 0.927

6.  Non-target molecular network and putative genes of flavonoid biosynthesis in Erythrina velutina Willd., a Brazilian semiarid native woody plant.

Authors:  Daisy Sotero Chacon; Marlon Dias Mariano Santos; Bernardo Bonilauri; Johnatan Vilasboa; Cibele Tesser da Costa; Ivanice Bezerra da Silva; Taffarel de Melo Torres; Thiago Ferreira de Araújo; Alan de Araújo Roque; Alan Cesar Pilon; Denise Medeiros Selegatto; Rafael Teixeira Freire; Fernanda Priscila Santos Reginaldo; Eduardo Luiz Voigt; José Angelo Silveira Zuanazzi; Kátia Castanho Scortecci; Alberto José Cavalheiro; Norberto Peporine Lopes; Leandro De Santis Ferreira; Leandro Vieira Dos Santos; Wagner Fontes; Marcelo Valle de Sousa; Paulo Costa Carvalho; Arthur Germano Fett-Neto; Raquel Brandt Giordani
Journal:  Front Plant Sci       Date:  2022-09-08       Impact factor: 6.627

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.